Frank Orlowski
Global Pfizer Pharmaceutical Finance Executive offering 25 years experience in global environments. Expertise in FCPA, improving financial audit readiness controls and supporting country specific revenue growth through new product launches, while driving opportunities to optimize costs without compromising on quality, integrity, and product reliability. Active Board Member of the American Cancer Society and Advisor to prominent Venture Capital & Law Firms.
His experience includes:
- Leading large global teams responsible for $1.1B+ in global P&L across 35Countries managing over 200 FTE’s
- Removed $250MM+ of cost from Pfizer’s Product Supply Network over fouryears, including 11 global plant closures without compromising on quality andproduct reliability.
- Delivered $600MM+ of incremental revenue through cost of goods reduction,SKU harmonization and new product line extensions
- Global financial systems implementation lead, ERP, MRP and T&E, impacting 100% of Pfizer’s 125,000+ FTE’s
- Financially led global joint ventures in Russia, Brazil, and Turkey generatingover $350MM+ of sustainable yearly revenue for Pfizer
- Improved compliance and controls environment globally virtually eliminatingunsatisfactory financial audits and drastically reducing complianceinvestigations
- Raised over $1.5M+ and helping to launch their Venture Fund
Expertise
- Cost control, forecasting and operating plan development
- Acquisitions, due diligence, deal development divestitures and joint ventures
- Market access specialist
- FCPA, compliance and controls, audit readiness specialist
- Global contract negotiation in both public and private sector
Associations
- Member of the American Cancer Society Regional Board of Directors
Education and Training
- Master of Business Administration (MBA) in Finance and Information Technology, 2002 New York University (NYU) Stern School of Business
- Bachelor of Science (BS) in Accounting and Computer Science, 1993 Providence College
Languages
- Fluent in English and Spanish